CD274 and urinary bladder carcinoma: When it was used in combination with an α-PD-L1 antibody, bisdemethoxycurcumin, a naturally produced curcumin dimethoxy derivative, it was shown to reduce PD-L1 expression to provide a promising environment for T-cell responses against bladder cancer [66].